See more : Naqi Water Company (2282.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Nahdi Medical Company (4164.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nahdi Medical Company, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- WhiteHorse Finance, Inc. (WHF) Income Statement Analysis – Financial Results
- Bison Finance Group Limited (0888.HK) Income Statement Analysis – Financial Results
- Analogue Holdings Limited (1977.HK) Income Statement Analysis – Financial Results
- Grade Upon Technology Corp (6739.TWO) Income Statement Analysis – Financial Results
- BioPower Operations Corporation (BOPO) Income Statement Analysis – Financial Results
Nahdi Medical Company (4164.SR)
About Nahdi Medical Company
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 8.71B | 8.62B | 8.07B | 8.64B | 7.82B | 7.35B | 7.06B |
| Cost of Revenue | 5.28B | 5.10B | 4.76B | 5.76B | 5.86B | 5.42B | 5.05B |
| Gross Profit | 3.44B | 3.52B | 3.30B | 2.88B | 1.97B | 1.93B | 2.01B |
| Gross Profit Ratio | 39.43% | 40.86% | 40.97% | 33.32% | 25.16% | 26.27% | 28.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 67.60M | 68.82M | 52.24M | 310.64M | 310.20M | 260.73M | 243.14M |
| Selling & Marketing | 394.63M | 352.60M | 335.65M | 1.96B | 1.34B | 929.09M | 894.30M |
| SG&A | 1.98B | 421.43M | 387.88M | 1.79B | 1.17B | 1.26B | 1.25B |
| Other Expenses | 495.91M | 4.46M | 10.03M | -126.14M | 11.53M | 1.21M | 1.78M |
| Operating Expenses | 2.47B | 2.53B | 2.43B | 1.92B | 1.16B | 1.26B | 1.25B |
| Cost & Expenses | 7.75B | 7.63B | 7.19B | 7.68B | 7.01B | 6.68B | 6.30B |
| Interest Income | 56.82M | 12.13M | 2.96M | 5.45M | 12.26M | 0.00 | 10.95M |
| Interest Expense | 83.02M | 79.38M | 78.88M | 57.50M | 55.35M | 0.00 | 0.00 |
| Depreciation & Amortization | 618.08M | 596.64M | 570.64M | 518.13M | 495.33M | 143.04M | 136.53M |
| EBITDA | 1.64B | 1.61B | 1.51B | 1.47B | 1.32B | 788.64M | 899.53M |
| EBITDA Ratio | 18.86% | 18.56% | 18.08% | 17.10% | 16.72% | 11.03% | 12.68% |
| Operating Income | 960.96M | 1.00B | 919.57M | 959.27M | 812.82M | 667.49M | 758.57M |
| Operating Income Ratio | 11.03% | 11.64% | 11.40% | 11.10% | 10.39% | 9.08% | 10.75% |
| Total Other Income/Expenses | -16.71M | -64.65M | -62.30M | -64.25M | -44.99M | -6.80M | -10.95M |
| Income Before Tax | 944.25M | 937.93M | 857.27M | 894.45M | 768.63M | 638.80M | 751.95M |
| Income Before Tax Ratio | 10.84% | 10.89% | 10.63% | 10.35% | 9.82% | 8.69% | 10.66% |
| Income Tax Expense | 51.63M | 50.11M | 44.74M | 45.33M | 76.63M | 28.14M | 30.71M |
| Net Income | 892.62M | 887.81M | 812.53M | 849.12M | 692.00M | 610.65M | 721.24M |
| Net Income Ratio | 10.24% | 10.30% | 10.07% | 9.83% | 8.84% | 8.31% | 10.22% |
| EPS | 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.70 | 5.55 |
| EPS Diluted | 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.70 | 5.55 |
| Weighted Avg Shares Out | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M |
| Weighted Avg Shares Out (Dil) | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M | 130.00M |
Source: https://incomestatements.info
Category: Stock Reports